Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00419822 · ClinicalTrials.gov registry record · NA

Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Patients

A NA study of Breast Cancer, sponsored by Legacy Health System.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT00419822: Completed NA study of Breast Cancer, sponsored by Legacy Health System.

NCT00419822 is a NA study of Breast Cancer that has completed, run by Legacy Health System. The registered enrollment target is 30 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00419822, a NA study of Breast Cancer, has completed, sponsored by Legacy Health System.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study is for the woman who will have axillary (armpit) surgery as part of their breast cancer treatment. The purpose of this project is to evaluate if acupuncture is helpful to control pain and improve range of motion (arm movement). Another goal is to find out if women have an improvement in their quality of life. This study is being done in collaboration with the Oregon College of Oriental Medicine (OCOM).

Conditions Studied

Interventions

  • PROCEDURE Acupuncture
  • PROCEDURE Sham Acupuncture
  • OTHER Patient to receive standard care without Acupuncture or Sham Acupuncture.

Study Locations (1)

Oregon

  • Legacy Good Samaritan Hospital and Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2006-09
Phase NA
Legacy Health System

21 total trials

What the finished NCT00419822 record still lists

NCT00419822 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Acupuncture is the first listed.

NCT00419822 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT00419822 about?

NCT00419822 is a clinical study titled "Acupuncture in the Management of Post Operative Symptoms in Breast Cancer Patients". This study is for the woman who will have axillary (armpit) surgery as part of their breast cancer treatment. The purpose of this project is to evaluate if acupuncture is helpful to control pain and improve range of motion (arm movement). Another goal is to find out if women have an improvement in t...

What is the current status of trial NCT00419822?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2006-09.

What conditions does trial NCT00419822 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00419822?

The interventions under investigation include: Acupuncture (PROCEDURE), Sham Acupuncture (PROCEDURE), Patient to receive standard care without Acupuncture or Sham Acupuncture. (OTHER).

Who is sponsoring clinical trial NCT00419822?

This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00419822 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00419822's enrollment target sits among peer trials

30 955th of 1224 higher than 227 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00419822, the US trial registry maintained by the National Library of Medicine. NCT00419822 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.